Deep-Dive

Every two weeks, we delve into detailed analyses of the latest policy initiatives, funding mechanisms, and healthcare delivery channels impacting access to innovative medicines in China.

Apr

Access Pathway for Innovative Medicines in China: Pure Commercial Health Insurance

In the last installment, we introduced City Commercial Health Insurance (City CHI), a type of all-inclusive commercial health insurance positioned

Apr 26, 2023

5 min read

Apr

Access Pathway for Innovative Medicines in China: City Commercial Health Insurance ("Huiminbao")

In the first installment of this 3-part China access pathway series, we discussed the basic social medical insurance (BMI)/the

Apr 19, 2023

5 min read

Apr

Access Pathway for Innovative Medicines in China: Basic Social Medical Insurance

To understand the access pathways for innovative medicines in China, we have to follow the money. Three layers in China’

Apr 12, 2023

7 min read